Premium
Mastitis treatment—Reduction in antibiotic usage in dairy cows
Author(s) -
Krömker V,
Leimbach S
Publication year - 2017
Publication title -
reproduction in domestic animals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.546
H-Index - 66
eISSN - 1439-0531
pISSN - 0936-6768
DOI - 10.1111/rda.13032
Subject(s) - mastitis , udder , antimicrobial , business , livestock , dairy cattle , production (economics) , animal welfare , welfare , antibiotics , medicine , dairy industry , antibiotic resistance , microbiology and biotechnology , environmental health , intensive care medicine , economics , biology , zoology , food science , market economy , ecology , macroeconomics , pathology
Contents Animal‐friendly, economical, resource‐saving milk production provides the basis for sustained consumer acceptance. Bovine mastitis plays a decisive role in the dairy industry—disturbing animal health and welfare and causing considerable economic losses on the other hand. Currently, antimicrobial treatment is indispensable to keep bovine udder health, animal welfare and economic aspects in balance. On the contrary, emergence and spread of antimicrobial resistance ( AMR ) is an urgent matter of particular public interest, and as a consequence, antimicrobial usage ( AMU ) in production livestock is a critically discussed subject. In urgent need of future reduction in AMU in the dairy industry, this review article describes and discusses possible approaches promising prompt implementation, including therapeutical alternatives as well as pro‐ and metaphylactic concepts such as the implementation of evidence‐based mastitis therapy concepts and selective dry cow treatment ( sDCT ), in search of the most effective and contemporary methods for decreasing AMU and AMR in dairy production.